Cladribine tablets in people with relapsing multiple sclerosis: a real-world multicentric, multinational study

被引:0
|
作者
Adamec, I. [1 ]
Jakob, G. Brec [2 ]
Rajda, C. [3 ]
Drulovic, J. [4 ]
Radulovic, L. [5 ]
Kes, V. Basic [6 ]
Lazibat, I. [7 ]
Rimac, J. [8 ]
Cindric, I. [9 ]
Grzincic, T. [10 ]
Abicic, A. [11 ]
Barun, B. [1 ]
Gabelic, T. [1 ]
Gomezelj, S. [2 ]
Pekmezovic, T. [2 ,12 ]
Klivenyi, P. [3 ]
Skoric, M. Krbot [1 ]
Habek, M. [1 ]
机构
[1] Univ Hosp Ctr Zagreb, Dept Neurol, Zagreb, Croatia
[2] Univ Med Ctr Ljubljana, Dept Neurol, Ljubljana, Slovenia
[3] Univ Szeged, Dept Neurol, Szeged, Hungary
[4] Univ Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia
[5] Clin Ctr Montenegro, Dept Neurol, Podgorica, Montenegro
[6] Sestre Milosrdnice Univ Hosp Ctr, Dept Neurol, Zagreb, Croatia
[7] Univ Hosp Dubrava, Dept Neurol, Zagreb, Croatia
[8] Natl Mem Hosp Dr Juraj Njavro Vukovar, Dept Neurol, Vulovar, Croatia
[9] Gen Hosp Virovitica, Dept Neurol, Virovitica, Croatia
[10] Gen Hosp Bjelovar, Dept Neurol, Bjelovar, Croatia
[11] Gen Hosp Zabok, Zabok, Croatia
[12] Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-091
引用
收藏
页码:180 / 180
页数:1
相关论文
共 50 条
  • [21] Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers
    Conway, Devon S.
    Nicholas, Jacqueline A.
    Thompson, Nicolas R.
    Mowry, Ellen M.
    Naismith, Robert T.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 94
  • [22] Real-World Experience in an Irish Centre using Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis
    O'Donnell, Martin
    Pavalaghanthan, Hariesh
    Jose, Shinto
    Mitten, Ethna
    Ryan, Aisling
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1000 - 1001
  • [23] Real-world use of cladribine tablets (Completion rates and treatment persistence) In patients with multiple sclerosis in England: the CLARENCE Study
    Brownlee, W.
    Amin, A.
    Ashton, L.
    Herbert, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 666 - 667
  • [24] Real-World Efficacy and Safety of Oral Cladribine in Korean Patients with Relapsing-Remitting Multiple Sclerosis
    Kim, Su-Hyun
    Kim, Ho Jin
    Kim, Sung Min
    Shin, Ha Young
    Kwon, Young Nam
    Nam, Tai-Seung
    Kim, Byoung Joon
    Min, Ju-Hong
    Kim, Jun Soon
    Su, Park Min
    Kim, Nam-Hee
    Shin, Jin-Hong
    Park, Young Eun
    Lim, Young-Min
    Lee, Eun-Jae
    Kim, Woojun
    Shon, Eun Hee
    Lee, Tae-Kyeong
    Taha, Karim
    Seo, Beom-Jun
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1099 - 1099
  • [25] Real-World Effectiveness of Cladribine Tablets in Individuals with Multiple Sclerosis: Data from a Multi-Center Italian Study
    Lucchini, Matteo
    Borriello, Giovanna
    Haggiag, Shalom
    Nicoletti, Carolina
    Fantozzi, Roberta
    Buscarinu, Maria Chiara
    Ferrazzano, Gina
    Cortese, Antonio
    Marinelli, Fabiana
    Monteleone, Fabrizia
    Centonze, Diego
    Conte, Antonella
    Ferraro, Elisabetta
    Gasperini, Claudio
    Marfia, Girolama Alessandra
    Pozzilli, Carlo
    Salvetti, Marco
    Barbuti, Elena
    Bianco, Assunta
    Carlomagno, Vincenzo
    Cruciani, Alessandro
    De Giglio, Laura
    Dionisi, Claudia
    Ianniello, Antonio
    Malimpensa, Leonardo
    Nasello, Martina
    Nociti, Viviana
    Prosperini, Luca
    Tortorella, Carla
    Mirabella, Massimiliano
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 376 - 377
  • [26] Real-world use of cladribine tablets (completion rates and treatment persistence) in patients with multiple sclerosis in England: The CLARENCE study
    Brownlee, Wallace
    Amin, Amerah
    Ashton, Luke
    Herbert, Alex
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [27] Cladribine use in multiple sclerosis: a monocentric real-world experience
    Pilotto, Silvy
    Mellino, Paolo
    Carmagnini, Daniele
    Frau, Jessica
    Coghe, Giancarlo
    Cocco, Eleonora
    Lorefice, Lorena
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 639 - 640
  • [28] Correction to: Cladribine Tablets: In Relapsing-Remitting Multiple Sclerosis
    Victoria J. Muir
    Greg L. Plosker
    CNS Drugs, 2020, 34 : 447 - 447
  • [29] Danish experience with cladribine tablets in the treatment of relapsing multiple sclerosis: a nationwide study
    Sorensen, P. S.
    Heick, A.
    Petersen, T.
    Joensen, H.
    Kopp, T. I.
    Sellebjerg, F.
    Magyari, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 165 - 165
  • [30] Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kurukulasuriya, Nuwan C.
    Greenberg, Steven J.
    Scaramozza, Matthew
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 123 - 136